genedrive plc (AIM:GDR)

Market Cap	11.33M
Revenue (ttm)	954.00K
Net Income (ttm)	-5.23M
Shares Out	1.03B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,254,770
Average Volume	6,444,800
Open	1.125
Previous Close	1.125
Day's Range	1.050 - 1.150
52-Week Range	0.190 - 2.400
Beta	0.97
RSI	62.09
Earnings Date	Dec 31, 2025

About genedrive

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 43
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: GDR

Financial Performance

In 2025, genedrive's revenue was 954,000, an increase of 90.42% compared to the previous year's 501,000. Losses were -5.23 million, -26.06% less than in 2024.